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Background: The recent evolution in treatments for peripheral vascular disease has dated available mortality statistics for
vascular intervention. Moreover, many of our current mortality statistics are derived from single-institution studies that
are often not reflective of outcomes in general practice. To provide current and generalizable data regardingmortality and
trends for peripheral vascular interventions, we examined two national data sets (Nationwide Inpatient Sample,
1998-2003, and National Hospital Discharge Survey, 1979-2003) and four states (New York, California, Florida, and
New Jersey, 1998-2003).
Methods: Four procedures—abdominal aortic aneurysm repair (nonruptured), lower extremity revascularization, ampu-
tation, and carotid revascularization—were selected by cross-referencing International Classification of Diseases, 9th
Revision, diagnostic and procedural codes. For significance, the t test was used for continuous variables, the 2 test was
used for dichotomous variables, and the 2 test was used for mortality trends.
Results: From 1998 to 2003, there was a progressive decrease in the national per capita rate of amputations: 13.2% overall
and 21.2% for major amputations (P< .0001). Nationally and regionally, mortality has only slightly declined. For lower
extremity revascularization, after a sharp increase during the 1980s to 100,000 open procedures, the volume remained
constant for 10 years and began to decline in 1998, reaching 70,000 cases in 2003. In contrast, since 1996, endovascular
interventions have increased 40%. Mortality during the 1998 to 2003 period remained virtually stable at 1.5% to 2% for
endovascular procedures and 3% to 4% for open procedures. The overall volume of abdominal aortic aneurysm repair has
not changed substantially for the past 6 years; however, endovascular repair is now used for nearly half the cases (46.5%
regional and 43.0% national). Mortality for open repair has not changed, remaining at approximately 5%, whereas for
endovascular repair, mortality has declined from 2.6% in 2000 to less than 1.5% in 2003. After the rapid increase in open
carotid revascularization in the early 1990s, the total volume has declined 5% nationally from 1998 to 2003. Regional
data demonstrated an overall 12% reduction in carotid revascularization volume since 1998; this reduction was due to a
16% decline in open carotid revascularization. During this same period, the use of angioplasty-stent carotid revascular-
ization doubled. Mortality for the open procedures is 0.5% and is significantly higher (2%-3%) for endovascular carotid
revascularization. Stroke rates for endovascular carotid revascularization are also higher: 2.13% vs 1.28% for open
procedures (P < .0001).
Conclusions: Dramatic shifts in the management of peripheral vascular disease have occurred together with an overall
decline in mortality. There seems to be a significant mortality advantage for endovascular as compared with traditional
surgery except for carotid endarterectomy. The increasing safety of vascular interventions should be considered when
deciding which patients to treat but with the caveat that endovascular interventions are not always safer than open repair.
(J Vasc Surg 2006;43:205-16.)Recent years have witnessed a substantial change in the
management of most common vascular diseases. Vascular
surgeons have played a pioneering role in the development
and introduction of new endovascular techniques, some of
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doi:10.1016/j.jvs.2005.11.002which have fundamentally changed the therapeutic options
for these patients. At the same time, we have seen the
development of new screening and diagnostic testing
methodologies and strategies. The availability of these new
diagnostic strategies and therapeutic regimens has affected
patient selection criteria and the patient populations that
ultimately receive vascular interventions.
Despite these developments, there has been little analysis
of the effect of these technological changes on the regional
and national volume of major vascular surgery. Moreover,
even less is known about their effect on patient outcomes.
Many of the often quoted mortality and morbidity rates are
out of date, and because they are generally derived from
single-institution or selective-series studies, they may not
reflect the outcomes seen in general practice.
205
domi
JOURNAL OF VASCULAR SURGERY
February 2006206 Nowygrod et alThis article addresses this lacuna by analyzing current
and generalizable data regarding mortality, morbidity,
and volume for the most common vascular interventions:
carotid revascularizations (CR), abdominal aortic aneu-
rysm repairs, lower extremity revascularizations, and am-
Table I. ICD-9 procedure and diagnosis codes
Category ICD-9 procedure codes
Carotids Open
38.12 Carotid endarterectomy
Endo
39.50 Angioplasty or atherectomy of noncorona
39.90 Insertion of non–drug-eluting, non–coron
artery stent(s)
AAA Open
38.34 Resection of abdominal aorta with anastom
38.44 Resection of abdominal aorta with replace
38.64 Other excision of vessels, abdominal aorta
39.52 Other repair of vessels, abdominal aorta
Endo
39.71 Endovascular implantation of graft in abdo
aorta
LER Open
39.29 Other (peripheral) vascular shunt or bypas
(excludes peritoneovenous shunt)
38.08 Embolectomy/thrombectomy lower limb
38.18 Endarterectomy lower limb arteries
38.38
38.48
38.88
Resection of lower limb arteries with anast
Resection of lower limb arteries with repla
Clamping/ligation/division/occlusion of
limb arteries
Endo
39.50 Angioplasty or atherectomy of noncorona
39.90 Insertion of non–drug-eluting, non–coron
artery stent(s)
Amputations Major
84.13 Disarticulation of ankle
84.14 Amputation of ankle through malleoli of t
fibula
84.15 Other amputation—below ankle
84.16 Disarticulation of knee
84.17 Amputation—above knee
All
84.1 Amputations of lower limb
84.3 Revision of amputation stump
ICD-9, International Classification of Diseases, 9th Revision;AAA, aortic ab
LE, lower extremity.putations. We examined two national data sets (theNational Hospital Discharge Survey [NHDS] and the
Nationwide Inpatient Sample) and four state databases
(New York, California, Florida, and New Jersey) from
the late 1990s through 2003. The national data sets are
projections based on a sample of hospitals. The state data
ICD-9 diagnosis codes
433.1 Carotid artery occlusion and stenosis
433.3 Multiple/bilateral carotid occlusion
435.9 Transient cerebral ischemia
362.3 Retinal vascular occlusion, unspecified
sel 362.8 Other retinal disorders
441.4 Abdominal aneurysm without mention of rupture
441.9 Aortic aneurysm of unspecified site without
mention of rupture
l
440.2 Atherosclerosis of extremities
250.7 Diabetes with peripheral circulatory disorders
443.9 Peripheral vascular disease
ies 444.22 Arterial embolism and thrombosis of LE
442.3 Aneurysm of artery of LE
is
nt
r
996.74 Other complications of internal prosthetic device,
implant, and graft due to other vascular device,
implant, and graft
sel
445.02 Atheroembolism, LE
440.20 ASO—Native arteries/extremities unspecified
nd 440.22
440.23
440.24
440.30
440.31
440.32
ASO—Native arteries/extremities with rest pain
ASO—Native arteries/extremities, with ulceratio
ASO—Native arteries/extremities, with gangrene
ASO—Unspecified bypass graft/extremities
ASO—Autologous vein/bypass graft/extremities
ASO—Nonautologous vein/bypass graft/
extremities
444.22 Arterial embolism and thrombosis of LE
447.1 Stricture of artery
707.1 Ulcer of lower limb, except decubitus
707.9 Chronic ulcer of unspecified site
729.5 Pain in limb
730.06 Acute osteomyelitis—lower leg
730.07 Acute osteomyelitis—ankle and foot
730.16 Chronic osteomyelitis—lower leg
730.17 Chronic osteomyelitis—ankle and foot
785.4 Gangrene
996.74 Complication—vascular device thrombosis
997.62 Amputation—chronic infection stump
998.59 Postoperative wound infection
250.7 Diabetes with peripheral circulatory disorders
nal aneurysm;ASO, atherosclerosis; LER, lower extremity revascularization;ry ves
ary
osis
ment
mina
s
arter
omos
ceme
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ry ves
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ibia asets offer valuable insights because they encompass all of
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constitute approximately 24% of the national hospital
discharges and a population base that is approximately
30% of the US census. In addition, the evolution of
treatment of peripheral vascular disease over the past 5
years was analyzed in an effort to project trends that are
Table II. List of ICD-9 codes for comorbidities and posto
Variable
ICD-9
Code
Comorbidities
Diabetes 250 Diabetes mellitus
Hypertension 401 Essential hypertension
402 Hypertensive heart disease
403 Hypertensive renal disease
404 Hypertensive heart and renal di
405 Secondary hypertension
Emphysema 490 Bronchitis, not specified as acut
491 Chronic bronchitis
492 Emphysema
493 Asthma
494 Bronchiectasis
496 Chronic airway obstruction, no
Coronary 413 Angina pectoris
414 Other forms of chronic ischemi
412 Old myocardial infarction
429.2 Cardiovascular disease, unspecifi
Peripheral 443.9 Peripheral vascular disease, unsp
440 Atherosclerosis
Renal 585 Chronic renal failure
403 Hypertensive renal disease
582 Chronic glomerulonephritis wit
Cerebral 434 Occlusion of cerebral arteries
433 Occlusion and stenosis of prece
437 Other and ill-defined cerebrova
438 Late effect of cerebrovascular di
Lipids 272.0 Disorder of lipoid metabolism.
Hypotension 458.2 Hypotension. Iatrogenic hypote
458.8 Other specified hypotension
458.9 Hypotension, unspecified
Postoperative
complications
Cardiac 997.1 Cardiac complications. Cardiac
during or resulting from a pro
procedure. Heart failure durin
Perioperative
stroke
997.02 Iatrogenic cerebrovascular infar
Respiratory 997.3 Respiratory complications. Men
resulting from a procedure
518.5 Pulmonary insufficiency after tra
insufficiency following shock,
Bleeding 285.1 Acute posthemorrhagic anemia.
998.1 Hemorrhage or hematoma or se
Infection 998.5 Postoperative infection
998.59 Other postoperative infection. A
postoperative, subphrenic pos
996.62 Infection and inflammatory reac
other vascular device, implant
pump, vascular catheter (arte
Shock 998.0 Postoperative shock. Collapse N
(hypovolemic) (septic) during
ICD-9, International Classification of Diseases, 9th Revision; NOS, not othlikely to affect training, manpower, and future research.METHODS
Source of data. The NHDS is compiled annually by
the National Center for Health Statistics. This database
contains medical and demographic information from a
sample of discharge records selected from a national sample
tive complications
Description
hronic
here classified
t disease
d
pecified pathologic lesion in kidney
arteries
disease
hypercholesterolemia
during or resulting from a procedure. Cardiac insufficiency
re. Cardiorespiratory failure during or resulting from a
resulting from a procedure
or hemorrhage. Postoperative stroke
n syndrome resulting from a procedure. Pneumonia (aspiration)
and surgery. Adult respiratory distress syndrome. Pulmonary
ery, or trauma. Shock lung
ia due to acute blood loss
complicating a procedure
ss: postoperative intra-abdominal postoperative, stitch
ative, wound postoperative. Septicemia postoperative
due to internal prosthetic device, implant, and graft—due to
graft (arterial graft, arteriovenous fistula or shunt, infusion
dialysis) (venous)
uring or resulting from a surgical procedure. Shock (endotoxic)
esulting from a surgical procedure
specified.pera
sease
e or c
t elsew
c hear
ed
ecifie
h uns
rebral
scular
sease
Pure
nsion
arrest
cedu
g or
ction
delso
uma
surg
Anem
roma
bsce
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rial) (
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erwiseof acute care hospitals. Hospitals with fewer than six beds
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Veterans Administration hospitals, are excluded. Hospital
discharge data are collected by means of a stratified system
on the basis of the annual number of discharges and the
geographic location of each institution. From the nation’s
approximately 6000 hospitals, approximately 500 are se-
lected each year for inclusion in the NHDS. Discharges are
weighted to reflect the 33,000,000 annual discharges
across the nation. Descriptive statistics can be generated for
procedures, diseases, race, sex, age, region, and payer;
diagnosis and procedure codes can be determined on the
basis of survey data. Such statistics are reliably valid only
when the sample size is more than 30.1
The Nationwide Inpatient Sample (NIS), part of the
Healthcare Cost and Utilization Project, is an annual data-
base of hospital inpatient stays that is used by researchers
and policymakers to identify, track, and analyze national
trends in health care utilization, access, charges, quality,
and outcomes. This database encompasses hospital inpa-
tient stays from states participating in the Healthcare Cost
and Utilization Project (8 in 1988, gradually increasing to
35 in 2002). Typical discharge abstracts include demo-
graphics, diagnosis (primary and multiple secondary), pro-
cedures (primary and multiple secondary), charges, length
of stay, and outcomes. The NIS sample represents approx-
imately 20% of US community hospitals, defined by the
American Hospital Association as “all non federal, short
term, general, and other specialty hospitals, excluding hos-
pital units of institutions.” For our analysis, we used the
Inpatient Core File, which contains data for 100% of the
discharges from a sample of hospitals in participating states.
The four state agencies providing regional data were
(1) the New York State Health Department’s Statewide
Planning and Research Cooperative System; (2) Califor-
nia’s Office of Statewide Health Planning and Develop-
ment; (3) New Jersey’s Department of Health and Senior
Service UB92; and (4) the Florida State’s Department of
Health, Florida Discharges Data Abstracts. These data sets
followed the Uniform Hospital Minimum Discharge Data
Survey’s recommendations and include: principle and mul-
tiple secondary diagnoses, and principle and multiple pro-
cedure codes (International Classification of Diseases, 9th
Revision, Clinical Modification), length of stay, and out-
come. Complication rates and comorbidity data were com-
piled from the regional databases (1998-2003 combined)
to avoid the small and variable sample size projections of
the NHDS and NIS. NIS rather than NHDS data were
used for the national analyses when the sample sizes for the
NHDS data were too small to be statistically reliable.
Patient populations. Treatment groups were identi-
fied by matching all relevant procedure codes with the
primary and two secondary diagnostic codes. Four groups
were analyzed: CR, abdominal aortic aneurysm repairs
(excluding ruptures), lower extremity revascularizations,
and lower limb amputations. The diagnosis/procedure
code groupings and linkages (Table I, online only) were
selected on the basis of experience from prior studies2-4 and
a survey of practitioners to ascertain which codes were mostcommonly used clinically. We assessed the following co-
morbidities (primary and all secondary diagnoses): diabe-
tes, hypertension, emphysema, coronary disease, peripheral
vascular disease, renal disease, cerebrovascular disease, and
disorders of lipid metabolism. Complications included (pri-
mary and all secondary diagnoses) cardiac, postoperative
stroke, respiratory complications, bleeding, infection, and
shock. A list of International Classification of Diseases, 9th
Revision (ICD-9), diagnosis codes for comorbidities and
complications is provided in Table II (online only).
Statistics. For the per capita calculations, annual na-
tionwide census information was obtained from the Na-
tional Census Bureau for the years 1979 to 2003, and
results were expressed as the rate of the variable per
100,000 population. Univariate analyses were conducted
by using t tests for continuous variables and the Fisher exact
test for dichotomous variables.We used 2 test for trends to
analyze mortality data over time. Confidence intervals for
rates were calculated by using normal approximation to the
binomial distribution. Data sets were analyzed with SAS
version 9.1 (SAS Institute, Cary, NC).
RESULTS
Carotid revascularizations. After a rapid increase in
the volume of CR in the early 1990s (50%) that was
related, perhaps, to the outcome of several large random-
ized trials,5,6 the national volume of CR after 1998 slightly
decreased, reaching a rate of 120,000 cases per year (Fig 1).
Regional data demonstrated an overall 12% reduction in
CR volume since 1998; this was due to a 16% decline in
open CR (Table III and Fig 2A). The total volume, nation-
ally, declined 5% (Table III and Fig 2C). During this same
period of time, the use of angioplasty-stent CR more than
doubled (state data, 773 in 1998 to 1959 in 2003; national
data, 3233 in 1998 to 7518 in 2003; Table III). In sum-
mary, despite the increasing use of angioplasty-stent proce-
dures, carotid interventions, overall, seem to be declining.
Mortality, conversely, has been quite steady for
open CR, at a rate of 0.5%, but continues to evolve for
Fig 1. National change in the total number of carotid procedures
(based on the National Hospital Discharge Survey). endo, Endo-
vascular.angioplasty-stent procedures (Fig 2B and D). In 1998, the
r proc
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mately 2% regionally and 3% nationally. These rates de-
creased to approximately 1% in 2002 but again increased in
Fig 2. Per capita use (A andC) and mortality (B andD)
number of cases from 1998 to 2003 was 36,087, 35,02
and 773, 1124, 1316, 1496, 1653, and 1959 for end
Nationwide Inpatient Sample), the number of cases fro
138,731, and 131,565 for open procedures and 323
procedures, respectively. *P  .05, open cf endovascula
Table III. Change in volume of vascular procedures
Variable
NIS
1998 2003
AAA*
Open 36,172 21,515
Endo 2,287 16,211
Total 38,459 37,726
Carotids
Open 143,643 131,565
Endo 3,233 7,518
Total 146,876 139,083
LER
Open 104,457 81,729
Endo 28,806 44,069
Combined 11,166 11,221
Total 144,429 137,019
Major amputations 65,560 55,574
All amputations 123,983 115,749
NIS, Nationwide Inpatient Sample; AAA, abdominal aortic aneurysm; LER
*Years for AAA: 2000 to 2003.2003.Analysis of comorbidities (Table IV) reveals a similar
percentage of diabetics in both groups (25%). Hyperten-
sion, chronic obstructive pulmonary disease (COPD), and
en and endovascular carotid procedures. Regionally, the
,053, 32,966, 31,622, and 30,324 for open procedures
ular procedures, respectively. Nationally (based on the
98 to 2003 was 143,643, 136,287, 137,752, 141,483,
396, 4410, 6567, 6518, and 7518 for endovascular
edures for each year.
States
Change 1998 2003 % Change
40.5 8,424 4,512 46.4
608.8 532 3,917 636.3
1.9 8,956 8,429 5.9
8.4 36,087 30,324 16.0
132.5 773 1,959 153.4
5.3 36,860 32,283 12.4
21.8 26,580 20,313 23.6
53.0 7,155 10,038 40.3
0.5 2,768 2,646 4.4
5.1 36,503 32,997 9.6
15.2 15,243 12,860 15.6
6.6 30,519 28,757 5.8
er extremity revascularization; Endo, endovascular.of op
0, 34
ovasc
m 19
3, 4%
, lowgeneralized cerebrovascular disease were more common in
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vascular disease, and hyperlipidemia were common in the
endovascular group.
The complication rates for both interventions are de-
picted in Table V. Cardiac complications were similar for
both (1.8%-2.1%), but the perioperative stroke rate was
significantly greater for the endovascular population
(2.13% vs 1.28%; P  .0001). Respiratory complications
were higher for open repairs, whereas bleeding complica-
tions were more frequent in the endovascular group.
Abdominal aortic aneurysm repairs. National and
regional findings are depicted in Fig 3 and Table III. In
reviewing the period from 2000 (when coding became
available for separating open from endovascular repair) to
2003, there has been a decline in overall volume: national
data set, from 38,459 to 37,726 (1.9%); regional, from
8,956 to 8,429 (5.9%). The proportion of endovascular
repairs, now used in almost half the patients, has increased
Table IV. Comorbid conditions*
Comorbidities Endo (%) Open (%) P value
Carotids
Diabetes mellitus 25.36 25.69 .4967
Hypertension 64.84 68.01 .0001
COPD 11.60 15.49 .0001
CAD 41.87 40.02 .0007
PVD 25.31 13.27 .0001
Renal 3.77 2.09 .0001
Cerebral 97.70 99.95 .0001
Lipids 22.77 16.40 .0001
AAA
Diabetes mellitus 14.29 10.50 .0001
Hypertension 63.33 59.97 .0001
COPD 28.94 33.26 .0001
CAD 45.96 40.16 .0001
PVD 14.84 17.30 .0001
Renal 3.68 4.06 .0676
Cerebral 3.75 4.11 .0945
Lipids 16.39 12.14 .0001
LER
Diabetes mellitus 39.68 43.90 .0001
Hypertension 58.76 61.75 .0001
COPD 14.78 20.86 .0001
CAD 39.22 38.35 .0007
PVD 79.82 76.88 .0001
Renal 12.38 10.12 .0001
Cerebral 7.39 6.69 .0001
Lipids 11.10 9.47 .0001
Major amputations
Diabetes mellitus 65.95
Hypertension 57.43
COPD 16.31
CAD 32.50
PVD 73.13
Renal 22.07
Cerebral 10.16
Lipids 3.59
Endo, Endovascular; AAA, abdominal aortic aneurysm; COPD, chronic
obstructive pulmonary disease; CAD, coronary artery disease; PVD, periph-
eral vascular disease; LER, lower extremity revascularization.
*Based on regional data.significantly (from 0.7/100,000 in 2000 to 4.9/100,000in 2003, up 608% in regional data sets, and from 0.8/
100,000 in 2000 to 5.6/100,000 in 2003, up 586% in
national data sets) and is paralleled by a decline in open
procedures (from 11.6/100,000 in 1998 to 5.6/100,000,
down 52% in regional data sets, and from 12.8/100,000 to
7.4/100,000 in 2003, down 41% in national data sets;
Table VI). Thus, the percentage of total repairs performed
with endovascular procedures went from 5.8% to 46.5%
regionally and from 6.3% to 43.0% nationally (2000-2003).
During the same period, the mortality of open repairs did
not change (state data: 5.1% in 1998 and 5.2% in 2003;
national: 4.3% in 1998 and 4.8% in 2003). Conversely,
endovascular repair mortality has declined from 2.6% in
2000 to less than 1.5% in 2003 regionally and from 2.1% in
2000 to 1.0% in 2003 nationally (Fig 3 and Table VII).
It is interesting to observe that important comorbidi-
ties (Table IV), such as diabetes, hypertension, coronary
artery disease, and hyperlipidemia, were more common in
the endovascular group. COPD and peripheral vascular
disease, by comparison, were more common in the open
group. Complication rates (Table V) were significantly
higher in the open repair population: cardiac (7.8% vs
2.8%), stroke (0.5% vs 0.2%), respiratory (15.4% vs 3.5%),
bleeding (17.1% vs 8.0%), infection (2.2% vs 0.6%), and
Table V. Postoperative complications*
Variable Complications
Endo
(%)
Open
(%) P value
Carotids
Cardiac 1.79 2.07 .0784
PO stroke 2.13 1.28 .0001
Respiratory 0.55 1.32 .0001
Bleeding 5.32 3.85 .0001
Infection 0.36 0.13 .0001
Shock 0.02 0.02 .544
AAA
Cardiac 2.83 7.75 .0001
PO stroke 0.22 0.53 .0001
Respiratory 3.54 15.36 .0001
Bleeding 8.00 17.10 .0001
Infection 0.59 2.23 .0001
Shock 0.13 0.50 .0001
LER
Cardiac 0.86 3.05 .0001
PO stroke 0.19 0.32 .0001
Respiratory 0.70 2.94 .0001
Bleeding 7.30 11.07 .0001
Infection 1.06 3.20 .0001
Shock 0.08 0.14 .0005
Major amputations
Cardiac 2.15
PO stroke 0.28
Respiratory 3.04
Bleeding 8.39
Infection 4.52
Shock 0.12
Endo, Endovascular; PO, perioperative; AAA, abdominal aortic aneurysm;
LER, lower extremity revascularization.
*Based on regional data.shock (0.5% vs 0.1%).
n cf e
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period from 1979 to 1998, open lower extremity recon-
structive procedures (including infrainguinal, direct, and
Fig 3. Per capita use (A andC) and mortality (B andD)
procedures. Regionally, the number of cases from 1998
open procedures and for years from 2000 to 2003 wa
Nationally (based on the Nationwide Inpatient Sample),
36,172, 26,886, 22,728, and 21,515 for open procedure
and 16,211 for endovascular procedures. *P  .05, ope
Table VI. Change in per capita use of vascular
procedures from 1998 to 2003
Variable
NIS States
% Change P value % Change P value
AAA
Open 41.52 .0001 51.66 .0001
Endo* 585.95 .0001 607.93 .0001
Carotids
Open 14.87 .0001 22.73 .0001
Endo 116.14 .0001 133.03 .0001
LER
Open 27.28 .0001 29.73 .0001
Endo 42.20 .0001 29.00 .0001
Major amputations 21.21 .0001 31.77 .0001
All amputations 13.23 .0001 13.36 .0001
NIS, Nationwide Inpatient Sample; AAA, abdominal aortic aneurysm;
Endo, endovascular; LER, lower extremity revascularization.
*Years for endovascular AAA: 2000 to 2003.extra-anatomic) more than doubled (Fig 4). Over thesubsequent 6 years (through 2003), despite a substantial
increase in the number of lower extremity endovascular
interventions (40% regional and 53% national), there was
Table VII. Mortality change for vascular procedures
from 1998 to 2003
Variable
NIS States
% Change P value % Change P value
AAA
Open 0.48 .0073 0.11 .7941
Endo* 1.15 .0001 1.18 .0422
Carotids
Open 0.11 .0086 0.13 .0235
Endo 0.84 .0001 0.72 .1884
LER
Open 0.49 .0001 0.57 .0011
Endo 0.57 .0001 0.14 .5098
Major amputations 0.03 .839 0.80 .014
All amputations 0.46 .0001 0.81 .0001
NIS, Nationwide Inpatient Sample; AAA, abdominal aortic aneurysm;
Endo, endovascular; LER, lower extremity revascularization.
*Years for endovascular AAA: 2000 to 2003.
en and endovascular abdominal aortic aneurysm (AAA)
003 was 8582, 8589, 8424, 6236, 5166, and 4512 for
, 2857, 3488, and 3917 for endovascular procedures.
umber of cases from 1998 to 2003 was 34,190, 34,983,
for years from 2000 to 2003 was 2287, 13,248, 13,069,
ndovascular procedures for each year.of op
to 2
s 532
the n
s andan overall decline in the total number of lower extremity
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9.6% according to state data; Table III and Fig 5A and C).
From the 1980s to the mid 1990s, there was a significant
decline in mortality, from approximately 7% to 4% nation-
ally (data not shown). However, mortality during 1998 to
2003 remained virtually stable at 1.5% to 2% for endovas-
cular procedures and 3% to 4% for open and combined
procedures (endovascular together with open; Table VII
and Fig 5B and D). Cardiac, stroke, respiratory, bleeding,
and infection complications were all significantly greater for
both the open procedures group and the open with endo-
vascular procedures group as compared with patients who
received endovascular interventions alone. These differ-
ences in complication rates occurred despite a relatively
similar overall incidence of comorbidities in the three pop-
ulations (Tables IV and V).
Amputations. The volume for major amputations na-
tionally and the volume of major and minor amputations
regionally have both declined (Table III and Fig 6). For the
period 1998 to 2003, regional state data reveal a 5.8%
overall decrease in volume; nationally, the decrease over the
same period was 6.6% (Table III). More significantly, how-
ever, there has been a 15.6% (state) and 15.2% (national)
decrease in major amputations in what continues to be a
high-risk group of patients: ie, those with diabetes (65.9%),
hypertension (57.4%), large-vessel peripheral vascular dis-
ease (73.1%), coronary artery disease (32.5%), renal insuf-
ficiency (22.1%), cerebrovascular disease (10.2%), and
COPD (16.3%) (Table IV). Overall mortality is declining,
but slowly, and remains more than 6% for major amputa-
tions nationally (Fig 6 and Table VII).
DISCUSSION
Our data support the general perception that dramatic
shifts toward endovascular treatments have occurred in the
management of peripheral vascular disease. Moreover, our
data demonstrate that there has been an overall decline in
treatment-related mortality, amputation rates, and compli-
cations. Given the growth and aging of the US population
Fig 4. National change in the total number of lower extremity
revascularization procedures (based on the National Hospital Dis-
charge Survey). endo, Endovascular.(24% overall increase from 1980 to 2000; 43% increase inthe age group65 years; and 67% increase in the age group
75 years; http://www.census.gov) and the increasing
utilization rate of vascular interventions in the elderly,2 it is
not surprising that we observed more than a doubling in
the number of vascular procedures from 1979 to 2003
(358,000 to 785,000).2 Less clear is the more recent (last 5
years of the analysis) stabilization or decline of volume in
vascular interventions. Possible explanations for this change
include greater public awareness and improved risk factor
management, a swing of the pendulum back toward con-
servative management of small aneurysms and asymptom-
atic carotid disease,7-12 or the effect of cost-containment
policies on utilization levels.
The decreased mortality and improved results with
endovascular aneurysm repair have been observed by others
and perhaps could be anticipated with improved device
technology, increasing experience, and the less invasive
nature of the procedure.2,13-16 The higher, and possibly
increasing, mortality of open aneurysm repair since 2000
(Fig 3B and D; Table VII) likely reflects the shift toward
treating more complex and morbid (juxtarenal and supra-
renal) aneurysms, because infrarenal aneurysms are more
commonly treated with endovascular techniques.
In addition, many patients who previously would have
been considered to represent good risks for open repair
have undergone, instead, endovascular aneurysm repair.
This would favorably influence the mortality/morbidity
rate for endovascular aneurysm repair in its recent period of
use (2000-2003) compared with its earlier use in predom-
inantly higher-risk patients. One of the limitations of large
data sets is the inability to define arterial anatomy. Presum-
ably, aneurysms are selected for endovascular repair because
they are not pararenal or lack significant iliac disease; both
factors increase the risk of open repair.
Other studies have noted that the increased use of
vascular interventions has led to improved limb salvage
rates.17-20 It is interesting to note that, for the period 1998
to 2003, our analyses demonstrate a decline in amputation
rates (Fig 6A and C) in parallel with the increasing applica-
tion of endovascular interventions (Fig 5A and C) and
despite a decrease in the overall number of lower extremity
revascularization procedures (Table III). Because patient
morbidity has not substantially changed, it is interesting to
speculate about whether the shifts toward endovascular
treatment and the possible attendant earlier interventions
might be a significant factor in this apparent outcomes
improvement. Another variable that affects these results is
the increasing application of endovascular interventions to
femoropopliteal disease, an area in which it had not previ-
ously been thought or have durable results. Of course,
other variables are operative, including changes in medical
and risk factor managements, as well as the current height-
ened focus on newer and more specialized wound care
treatments and methodologies. These issues merit further
analysis and study.
The major unexpected finding in this study is the
higher mortality (total and per capita, national, and re-
gional) and the higher stroke rate for carotid angioplasty-
JOURNAL OF VASCULAR SURGERY
Volume 43, Number 2 Nowygrod et al 213stent procedures compared with carotid endarterectomy,
despite the near equivalence of comorbidities in the two
groups (Fig 2B and D; Table IV). These findings are at
odds with other studies that have demonstrated equiva-
lence or improved results for angioplasty-stent treatment
compared with open carotid endarterectomy, particularly
in higher-risk patients.21-24 The logical explanation would
be that carotid angioplasty and stenting were performed
preferentially on high-risk patients and that carotid endar-
terectomywas performed on a large number of low-risk and
some high-risk patients. There seems, however, to be sub-
stantial risk equivalence among the various treatment
groups25,26 (Table IV).
While acknowledging that there are constraints im-
posed by the complexities of working with large data sets,
we believe that we have indeed identified, through ICD-9
procedure and diagnostic codes, the subset of patients who
were treated with carotid stents. The ICD-9 procedure
code for carotid stenting was not created until 2004. Thus,
Fig 5. Per capita use (A andC) and mortality (B andD)
revascularization (LER) procedures. Regionally, the num
23,685, 21,625, and 20,313 for open procedures; 715
procedures; and 2768, 2817, 2701, 2602, 2640, and 26
on theNationwide Inpatient Sample), the number of case
90,301, and 81,729 for open procedures; 28,806, 30,9
procedures; and 11,166, 11,319, 10,771, 11,029, 10,5
.05, open cf endovascular procedures for each year.identifying patients who had undergone carotid stentingbefore the specific procedure code was issued required a
two-step process: first, finding patients who underwent an
intravascular stent procedure, and second, by using a dis-
ease code, identifying the subset of those patients who had
carotid disease and therefore were most likely to have had
the procedure performed in the carotid vasculature. We
accomplished this by first identifying a cohort of patients
who underwent both noncoronary angioplasty and stent
insertion (ICD-9 procedure codes 35.50 and 35.90) and
then selecting out a subset of those patients who had either
a carotid occlusion or a cerebral ischemic event as their
primary, secondary, or tertiary diagnosis (ICD-9 codes
433.1, 433.3, 435.9, 362.3, and 362.8).
The relative merits and outcomes for the treatment of
carotid stenosis are a shifting dynamic, which may soon
change with the recent increase in endovascular training
and the growth of experience of its various practitioners, as
well as the more ubiquitous use of embolic protection
devices. This is evident in the gradually decreasing mortal-
en, endovascular (endo), and combined lower extremity
f cases from 1998 to 2003 was 26,580, 25,852, 24,760,
299, 7857, 8194, 8429, and 10,038 for endovascular
r combined procedures, respectively. Nationally (based
1998 to 2003 was 104,457, 102,457, 97,387, 97,247,
31,242, 40,068, 37,882, and 44,069 for endovascular
d 11,221 for combined procedures, respectively. *P of op
ber o
5, 7
46 fo
s from
47,
15, anity with carotid stenting from 2000 to 2002 (Fig 2B and
rtalit
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coincide with a new wave of entering novice practitioners
and extension of the procedure to patients who tradition-
ally would have received no treatment.
Of course, one of the weaknesses of large data set
analysis is that fine-grained clinical detail and physiological
variables (eg, blood pressure, ejection fraction, and ana-
tomic characteristics of the aneurysm) are not included; this
hampers our ability to assess the severity of illness and, thus,
make unbiased comparisons between treatment groups.
Other weaknesses of this type of data set include variabili-
ties and lapses in coding, missed cases, and procedural
“contaminations,” such as including coronary or intracere-
bral endovascular interventions with the carotid and lower
extremity groups. In addition, a limitation of claims data is
that we can analyze only conditions that were diagnosed
and records of care received: we know little about the
outcomes of patients for whom treatment was not initiated.
Because these data bases identify only inpatient admissions,
procedures performed in an outpatient setting are not
captured. Finally, we did not have access to patient identi-
Fig 6. Per capita use (A and C) and mortality (B and
number of cases from 1998 to 2003 was 15,243, 14,378
29,243, 29,566, 29,645, 28,686, and 28,757 for all am
Inpatient Sample), the number of cases from 1998 to 20
for major and 123,983, 120,942, 123,004, 121,505, 119
for trend of all amputation procedures. **P value for mofiers, and thus we cannot conduct a longitudinal analysis orcharacterize their baseline health on the basis of pre-
existing diseases.
To help minimize the effect of these problems, we
examined the two major and widely used national data sets,
as well as four separate state data sets. We compared the
findings among all these data sets for significant disparities.
We linked diagnosis and procedure codes. For example, in
extracting endovascular extremity cases, procedure codes
for extracoronary angioplasty and stenting were combined
with diagnosis codes specific for extremity arterial occlusive
disease. State data were deemed most reliable because,
unlike the national surveys, these record actual numbers,
rather than projections from a sample of hospitals. For
these reasons, to avoid projection distortions related to
small and highly variable sample sizes, the morbidity and
complications data were based on the regional rather than
the national surveys. The data from the four states and the
national data, where sample sizes permitted reliable analy-
sis, were consistent in overall trends.
Making predictions about future volume trends on the
basis of this analysis can be somewhat hazardous. Our
f major and all amputation procedures. Regionally, the
11, 14,021, 13,302, and 12,860 for major and 30,519,
ions, respectively. Nationally (based on the Nationwide
s 65,560, 62,875, 63,242, 61,457, 58,952, and 55,574
, and 111,143 for all amputations, respectively. *P value
y trend of major amputation procedures.D) o
, 14,2
putat
03 wa
,782current review and previous reviews2-4 have documented
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of surgical and nonsurgical therapies will be clinical
variables, including medical management of atheroscle-
rotic disease, biological and genetic engineering ad-
vances, and the use of vascular growth factor and endo-
thelial progenitor cells, as well as public policy and
economic changes in patient screening, device approvals,
and reimbursements. However, what seems quite clear
from this analysis is the increasing use and utility of the
less invasive procedures and, in general, their effective-
ness and safety.
CONCLUSIONS
Despite a dramatic shift from open to less invasive and
less morbid endovascular interventions, the total procedure
volume has recently stabilized or declined in all categories.
Endovascular approaches are supplanting open surgery.
Although significant systemic comorbidities seem, overall,
not greatly disparate between the two groups, mortality
and major complications are, except in the case of carotid
patients, markedly reduced with endovascular treatment.
For carotid interventions, whereas cardiac, pulmonary, and
bleeding complications are decreased with balloon angio-
plasty and stenting, both mortality and stroke rates have
been, at least until recently, significantly higher with stent-
ing vs carotid endarterectomy. This argues for the creation
of a clinical registry that would address some of the short-
comings of large data set analysis and would provide a
real-time look at the evolution of carotid interventions in
everyday clinical practice.
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Dr Gregorio A. Sicard (St Louis, Mo). I’m a little curious
about the carotid data. Are these primarily New York data?
Dr Nowygrod. The carotid data go through 2003 and are
consistent for the four regional states’ data, which comprise about a
third of the national population, as well as the two major national
surveys, the NHDS and NIS. So across the board, at least through
2002 to 2003, the endovascular approach does not compare favor-
ably.
Now, this doesn’t look at the last 2 years’ data, and it does
not include the more recent experience with increasing utiliza-
tion of embolic safety devices. And again, if we can focus on that
second curve depicting the national data trends, the difference
between the endovascular and open mortality does appear to be
narrowing.
Dr Peter Lawrence (Los Angeles, Calif). My question has to
do with the accuracy of the coding. In carotid artery stenting thereis currently no reimbursement, so I’m wondering whether or not
there might be more carotid artery stenting performed than your
data would show?
Dr Nowygrod. The coding issues were the most nettlesome
in putting these data together, but in the last 5 to 6 years’
experience, in looking at the 1998 through 2002 to 2003 data, the
coding and the numbers appear to be reasonable, accurate, and
reflective of actual data experience. If you look at the earlier data, in
the national surveys, the sample sizes are too small. For that reason,
we focused for most of the assessments, and for the endovascular
procedures in particular, on the recent (the 1998 through 2003)
period. That’s one reason we felt it necessary to use several differ-
ent data sets. In addition to the two major national data sets, we
used, as an internal control, the regional, four states’, data, where
the numbers, since they’re not based on probability projections
from sample sizes, are most accurate and reliable.
